NCT05866523Recruiting
Teamwork Makes the Dream Work
Teamwork Makes the Dream Work: Team-based Inpatient Anti-Retroviral Treatment and Access to Services (ARTAS)
Source: ClinicalTrials.gov · Last updated 27 Feb 2026
Brief summary (registry, in English)
Exploring the effect of team-based ARTAS intervention in an inpatient setting on HIV linkage to care and hospital readmission rates.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- First submitted
- 10 May 2023
- Start date
- 16 Oct 2023
- Primary completion date
- Dec 2026
- Lead sponsor
- Loma Linda University
- Diseases
- HIV
- NCT number
- NCT05866523
What you commit to
- Study type: Interventional
- Planned participants: 250
- From 16 Oct 2023 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- are under active care of an HIV specialist within the last 6 months
Age
- Less than 18 years of age (stand alone exclusion)
Other
- All three criteria must be present for exclusion:
- virally suppressed
- actively taking ART
Who the study is looking for
- 18 years of age or greater
- newly diagnosed HIV
- Known diagnosis of HIV not on ART within 30 days of admission
- Known HIV and not virally suppressed based on interview
- Known HIV and has not been under the care of an HIV specialist within the past 6 months
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Loma Linda University Medical Center Coordinator of this site? Confirm its status | Loma Linda | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.